The Ministry of Health (MoH) has ordered the withdrawal of Batch No. 517999 of Augmentin 250 mg for children, made by GlaxoSmithKline (GSK), from all public and private hospitals, medical centers, clinics and pharmacies as tiny plastic pieces could mix with the medicine due to a manufacturing failure. In a statement issued today, MoH's Assistant Undersecretary for Medical Practices and Licensing Dr Amin Hussein Al Amiri said the circular issued today by the Ministry also bans further imports of the same batch and orders GSK to provide a detailed report on the withdrawal of the drug and to provide enough quantities to make up for any possible shortage. All other batches of the said product are safe for human consumption and any side effects which might develop should however be reported online to the ministry, the official said.
GMT 14:01 2018 Thursday ,30 August
Expat with rare heart disorder gets life-saving surgeryGMT 00:18 2018 Tuesday ,23 January
Boy with 10-pound tumour on face diesGMT 21:23 2018 Monday ,22 January
All set for first global medical tourism conference in DubaiGMT 22:46 2018 Sunday ,21 January
Second face transplant for FrenchmanGMT 07:51 2018 Saturday ,20 January
Trio aquitted of negligence in Canada railway disasterGMT 10:57 2018 Thursday ,18 January
Breastfeeding for 6 months cuts diabetes risk in half: studyGMT 16:10 2018 Wednesday ,17 January
Child mummy in Italy had hepatitis, not smallpoxGMT 18:36 2018 Tuesday ,16 January
Greece strikes cause transport chaos, healthcare delays

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor